Cole Eye Institute Retina Summit 2018

Cole Eye Institute Retina Summit is organized by MCME Global Inc and will be held on Apr 27, 2018 at Sheraton Waikiki Hotel, Honolulu, Hawaii, United States of America.

The target audience for this medical event is retina specialists, comprehensive ophthalmologists, retina fellows and healthcare providers who are interested in applying the most recent advancements in the retinal medicine field, including emerging techniques for imaging and treating retinal and vitreoretinal diseases. This CME Conference has been approved for a maximum of 7.0 AMA PRA Category 1 Credits.

Course Description :
Retina experts will discuss recent clinical study results and their application to clinical practice; active clinical investigations of potential new therapies; applications of new imaging techniques; advances in surgical instrumentation, and the optimal management of retinal diseases. The program will have didactic presentations, surgical video panel discussions, and interactive case based sessions, with a dedicated audience question and answer session.

Course Topics :
• Clinical evidence for new and emerging therapies and treatment combinations for retinovascular diseases.
• Dietary and supplement recommendations.
• Correlation between anti-VEGF injections and GA within the context of anatomic findings.
• Available treatment options for central serous chorioretinopathy.
• Sequence, dose, safety, efficacy, and durability of combination therapies for wet AMD leading to successful patient outcomes.
• Knowledge of clinical evidence and what recent trials have taught us about real-life treatments.
• Background on strategies associated with investigational therapies for dry AMD and DME.
• Practical insights into integrating new imaging technologies into clinical practice.
• Familiarity with imaging modalities for early detection, disease typing, disease monitoring, and surgical intervention.
• Surgical best practices and post-operative care, including video demonstrations of new surgical techniques and technologies.
• Optimal surgical outcomes for patients.

Course Goals :
The overall learning objectives of this educational symposium are to:
• Assess treatment strategies and outcomes, including management options for patients with DME.
• Identify therapeutic options for the management of treatment-resistant AMD.
• Integrate available technologies into clinical practice for early detection, disease typing, and disease monitoring.
• Optimize the timing of patient assessment and care in patients with vitreoretinal interface diseases.
• Adopt best practices in surgery and post-operative care of patients with retinal disease.
• Summarize recent clinical trial data and what we’ve learned for retinal diseases.

Additional details will be posted as soon as they are available.